Amy Vandenberg Net Worth & Insider Trades
Amy Vandenberg - Chief Clinical & Reg Officer, Obalon Therapeutics Inc
What is Amy Vandenberg's Net Worth?
The current estimated net worth of Obalon Therapeutics Inc's Chief Clinical & Reg Officer, Amy Vandenberg, is estimated to be about $47.06K . Amy Vandenberg owns about 11,764 units of Obalon Therapeutics Inc common stock. In the last 4 years at Obalon Therapeutics Inc, Amy Vandenberg has sold an estimated value of $0 worth.
What is Amy Vandenberg's Past Insider Trading?
Amy Vandenberg's largest purchase order was 2,500 units , worth over $10K on August 8, 2019. In total, Amy Vandenberg has made about 11 transactions over 4 years of their time at Obalon Therapeutics Inc. Amy Vandenberg usually trades in January, with the busiest year in 2019.
Amy VandenBerg
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Amy Vandenberg's' Mailing Address?
- Mailing address is C/o Obalon Therapeutics, Inc. 5421 Avenida Encinas, Suite F Carlsbad CA 92008 CA
What are Obalon Therapeutics Inc's Past Insider Trades?
Obalon Therapeutics Inc's most recent insider trade came on November 14, 2019 by William J Plovanic who bought 65,000 units worth $107.82K . In the last 3 years, insiders at Obalon Therapeutics Inc have sold an estimated value of $10K and bought an estimated value of $7.97M worth of shares. Insider trading is most common in August, with the busiest year in 2018. The most active traders at the company are William J Plovanic, Amy Vandenberg, Chief Clinical & Reg Officer, and Mark Brister, Chief Technology Officer .
OBALON THERAPEUTICS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||